Prospects for new antibiotics: keeping one step ahead.
D000617:Aminoglycosides / Q000627:therapeutic use; D000871:Anthelmintics / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy; D055598:Chemical Phenomena; D002621:Chemistry; D006801:Humans; D007769:Lactams; D008826:Microbial Sensitivity Tests; D009268:Nalidixic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D011528:Protozoan Infections / Q000188:drug therapy; D011804:Quinolines / Q000494:pharmacology; D013329:Structure-Activity Relationship
D000617:Aminoglycosides; D000871:Anthelmintics; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000935:Antifungal Agents; D007769:Lactams; D011804:Quinolines; D009268:Nalidixic Acid